Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Authors
Keywords
-
Journal
EUROPEAN RESPIRATORY JOURNAL
Volume -, Issue -, Pages 2200780
Publisher
European Respiratory Society (ERS)
Online
2022-07-28
DOI
10.1183/13993003.00780-2022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A guide to immunotherapy for COVID-19
- (2022) Frank L. van de Veerdonk et al. NATURE MEDICINE
- Long-term clinical outcomes of COVID-19 patients treated with imatinib
- (2022) Erik Duijvelaar et al. Lancet Respiratory Medicine
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers
- (2021) Ninh T. Nguyen et al. JAMA Network Open
- Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
- (2021) Anno Saris et al. THORAX
- Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients
- (2021) Esther J. Nossent et al. Frontiers in Immunology
- Clinical features and prognostic factors in Covid-19: A prospective cohort study
- (2021) Sanne de Bruin et al. EBioMedicine
- Latent Class Analysis Reveals COVID-19-related ARDS Subgroups with Differential Responses to Corticosteroids
- (2021) Pratik Sinha et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
- (2021) Jurjan Aman et al. Lancet Respiratory Medicine
- Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19
- (2021) Daniel E. Leisman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immune interventions in COVID-19: a matter of time?
- (2021) Léo Plaçais et al. Mucosal Immunology
- Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts
- (2021) Lieuwe D J Bos et al. Lancet Respiratory Medicine
- Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
- (2021) Zelalem Temesgen et al. Lancet Respiratory Medicine
- Who, what, and when—effective therapy for severe COVID-19
- (2021) Daniel A Kelmenson et al. Lancet Rheumatology
- Immunomodulation in COVID-19
- (2020) Nicholas E Ingraham et al. Lancet Respiratory Medicine
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
- (2018) Carolyn S Calfee et al. Lancet Respiratory Medicine
- Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation
- (2018) Thomas Bärnthaler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
- (2018) David M Kent et al. BMJ-British Medical Journal
- Stan: A Probabilistic Programming Language
- (2017) Bob Carpenter et al. Journal of Statistical Software
- Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis
- (2017) L D Bos et al. THORAX
- ARDS Subphenotypes Respond Differently to Randomized Fluid Management Strategy
- (2016) Katie R Famous et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury
- (2015) E. Letsiou et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury
- (2015) Alicia N. Rizzo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Learning Bayesian Networks with thebnlearnRPackage
- (2015) Marco Scutari Journal of Statistical Software
- NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
- (2015) Malika Charrad et al. Journal of Statistical Software
- Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials
- (2014) Carolyn S Calfee et al. Lancet Respiratory Medicine
- Abl Family Kinases Regulate Endothelial Barrier Function In Vitro and in Mice
- (2013) Elizabeth M. Chislock et al. PLoS One
- Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib
- (2012) Jurjan Aman et al. CIRCULATION
- Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients
- (2010) Rogier M Determann et al. BMC Pulmonary Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now